1Adams KF. Post hoc subgroup analysis and the truth of a clinical trial [J]. Am Heart J, 1998,136: 751- 758.
2Stevenson LW,Braunwald E. Recognition and management of patients with heart failure. Primary Cardiology [M]. Philadelphia : WB Saunders, 1998 : 310- 329.
3Stein BC ,Levin RI. Natriuretic peptides:physiology, therapeutic potential, and risk stratification in ischemic heart disease[J]. Am Heart J, 1998,135:914- 923.
4Nagagawa O, Ogawa Y, Itoh H,et al. Rapid transcriptional activation and early mRNA turnover of BNP in cardiocyte hypertrophy. Evidence for BNP as an "emergency" cardiac homone against ventricular overload[J]. J Clin Invest, 1995,96: 1280-1287.
6Wallen T,LandahI S,Hedner T,et al. Brain natriuretic peptide predicts mortality in the elderly [J]. Heart,1997,77:264-267.
7Kojima M,Minamino M,Kangawa K,et al. Cloning and sequence analysis of cDNA encoding a precursor for rat brain natrluretic peptide [J]. Biochem Biophy Res Commun, 1989,159 : 1420-1426.
8Richards AM. The rennin angiotensin-aldosterone system and the cardiac natriuretic peptides[J]. Heart, 1996,76 (S3) : 36-44.
9Tsutamoto T, Wada A, Maeda K, et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heaet failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction[J]. Circulation, 1997,96 : 509-516.
10Kelly TL,Cremo R,Nieosen C,et al. Prediction of outcome in late-stage cardiomyopathy [J]. Am Heart J, 1990,119 : 1111-1121.
4Mueller T,Gegenhuber A,Poelz W,et al. Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emer gency diagnosis of heart failure[J] Heart, 2005,91(5) :606 612.
5Gill D, Seidler T, Troughton RW, et al. Vigorous response in plas ma N-terminal pro-brain natriuretic peptide (NT-BNP) to acute myocardial infarction[J]. Clin Sci ( Lond), 2004, 106(2) : 135 139.
6Redfield MM,Rodeheffer RJ ,Jacobsen SJ, et al. Plasma brain na triuretic peptide concentration:impact of age and gender[J]. J Am Coil Cardiol,2002,40(5) :976 982.
7Windgassen EB, Funlowicz L, Lunsford TN, et al. C-reactive pro tein and high-sensitivity C-reactive protein an update for c|ini cians[J].Postgrad Med,2011,123(1):114 119.
8Meuwese CL, Stenvinkel P, Dekker FW, et al. Monitoring of in flammation in patients on dialysis: forewarned is forearmed[J]. Nat Rev Nephrol,2011,7(3) :166 176.
9Kim SJ, Shin ES, Lee SG. N-terminal pro-B-type natritretic pep- tide as a marker of disease severity in patients with perieardial ef- fusions[J]. Korean J Intern Med, 2008,23(2) :78-86.
10Kahveci G, Bayrak F, Mutlu B, et al. Prognostic value of N-termi- nal pro B-type natritretic peptide in patients with active infective endocardltis[J]. Am J Cardiol, 2007,99 (10) : 1429-1433.
